Asia Pacific Neurovascular Devices Market Size & Outlook
Asia Pacific neurovascular devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific neurovascular devices market highlights
- The Asia Pacific neurovascular devices market generated a revenue of USD 641.9 million in 2023.
- The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
- Neurothrombectomy Devices is the most lucrative device segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 641.9 million |
| Market revenue in 2030 | USD 1,092.8 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Neurothrombectomy Devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.3% of the global neurovascular devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,092.8 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.85% in 2023. Horizon Databook has segmented the Asia Pacific neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific neurovascular devices market is majorly driven by increasing incidence of acute ischemic stroke. In addition, emerging economies such as China, Japan, South Korea, and India are expected to witness considerable growth over the forecast period.
Presence of several local players in China and Japan is expected to boost the market growth. Rising awareness about neurological disease treatment options and improvements in clinical development framework of emerging economies are expected to drive the market growth.
Furthermore, establishment of organizations such as the Asia-Pacific Centre for Neuromodulation (APCN), which is founded for conducting research and promoting awareness about associated benefits of deep brain stimulation surgeries, is anticipated to boost market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific neurovascular devices market size, by country, 2018-2030 (US$M)
Asia Pacific Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
